In the 2020-21 Budget, the government forecast spending on the sub-function of $15.104 billion in 2023-24. This has steadily risen and was $19.106 billion in the 2023-24 Budget, matching what was seen for 2022-23.
A one-off annual impact when it comes to spending growth is unlikely
September 19, 2023 Latest NewsBioPharma
Latest Video
New Stories
-
Landmark trial confirms survival benefit of Lilly therapy in high-risk early breast cancer
October 18, 2025 - - Latest News -
The 'Dispatched' Week in Review Podcast - 17 October
October 17, 2025 - - Podcast -
New partnership aims to strengthen local cell and gene manufacturing capability
October 16, 2025 - - Australian Biotech -
Vertex announces New Zealand registration of next-generation cystic fibrosis treatment
October 16, 2025 - - Latest News -
Lilly’s oral GLP-1 therapy delivers strong results in late-stage diabetes trials
October 16, 2025 - - Latest News -
NDIS participant numbers and spending continue growth trajectory in latest quarterly data
October 15, 2025 - - Other Health -
Key Pharmaceuticals builds on a 40-year legacy to support frontline health
October 15, 2025 - - Latest News